These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9864077)

  • 1. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder.
    Greil W; Kleindienst N; Erazo N; Müller-Oerlinghausen B
    J Clin Psychopharmacol; 1998 Dec; 18(6):455-60. PubMed ID: 9864077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to mood stabilizers.
    Calabrese JR; Fatemi SH; Kujawa M; Woyshville MJ
    J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium safety in the prophylaxis of bipolar disorders: a study with plasma levels.
    Mauri MC; Laini V; Scalvini ME; Volonteri LS; Ferrari MS; Panza G
    Eur Rev Med Pharmacol Sci; 1999; 3(2):63-9. PubMed ID: 10827806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
    Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study.
    Maj M; Pirozzi R; Bartoli L; Magliano L
    J Affect Disord; 2002 Sep; 71(1-3):195-8. PubMed ID: 12167516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.
    Garnham J; Munro A; Slaney C; Macdougall M; Passmore M; Duffy A; O'Donovan C; Teehan A; Alda M
    J Affect Disord; 2007 Dec; 104(1-3):185-90. PubMed ID: 17442400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Vieta E; Cruz N; García-Campayo J; de Arce R; Manuel Crespo J; Vallès V; Pérez-Blanco J; Roca E; Manuel Olivares J; Moríñigo A; Fernández-Villamor R; Comes M
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Bryan AL; Ali SO; Post RM
    Am J Psychiatry; 1997 Oct; 154(10):1456-8. PubMed ID: 9326833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.
    Kleindienst N; Greil W
    Psychol Med; 2002 Apr; 32(3):493-501. PubMed ID: 11989994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on lithium treatment of bipolar disorder: action, efficacy, effect on suicidal behavior.
    Schou M
    Bipolar Disord; 1999 Sep; 1(1):5-10. PubMed ID: 11256657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients.
    Hartong EG; Moleman P; Hoogduin CA; Broekman TG; Nolen WA;
    J Clin Psychiatry; 2003 Feb; 64(2):144-51. PubMed ID: 12633122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.